Additional file 1: of Elucidating the transcriptional program of feline injection-site sarcoma using a cross-species mRNA-sequencing approach

Table S1. Sample information for the FISS transcriptome profiling. Each row corresponds to an RNA sample. Columns are as follows: sample name, the coded sample name used within this manuscript; biosample type, indicates whether the sample came from primary tissue or cultured cells; normal or cancer, distinguishes whether the sample is normal or cancerous; tissue type, gives the tissue subtype, such as sarcoma, skin, or muscle; Cat, the coded cat patient ID for this study; batch, the mRNA-seq batch number (see Methods); “#reads”, the total number of reads derived from the sample; “#uniquely mapped reads”, the number of reads that mapped to a unique location in the cat genome; %alignment, the percentage of the total number of reads that aligned to a unique location in the cat genome; #genes with non-zero count, the number of genes for which the count of aligned reads is greater than zero. (XLSX 11 kb)补充表S1. FISS转录组测序样本信息。每一行对应一个RNA样本，各列说明如下：样本名称：本文中使用的编码样本名；生物样本类型：指示样本来源于原发组织还是培养细胞；正常/癌性：区分样本为正常组织还是癌组织；组织类型：标注样本的组织亚型，如肉瘤、皮肤或肌肉；Cat：本研究中猫受试者的编码患者ID；批次：mRNA测序批次号（详见方法部分）；"#reads"：样本的总reads数；"#uniquely mapped reads"：唯一比对至猫基因组特定位置的reads数；"%alignment"：唯一比对至猫基因组特定位置的reads占总reads的百分比；"#genes with non-zero count"：比对reads计数大于0的基因数量。（XLSX格式，文件大小11 KB）